Drs. Bloom, Trump, and Samadi named to new posts

David A. Bloom, MD, has been appointed chairman of the department of urology at the University of Michigan Medical School in Ann Arbor. Dr. Bloom, a pediatric urologic surgeon who is the Jack Lapides Professor of Urology, replaces James E. Montie, MD, who relinquished the chairmanship to continue his research on the quality of care for patients with urologic cancer.

Dr. Bloom joined the U-M Medical School as an assistant professor and chief of pediatric urology in 1984. He became associate professor in 1986 and rose to his present rank of professor of urology in 1993. He was a member of the medical school’s admissions committee, served two terms on the executive committee on clinical affairs, and was appointed associate dean of the school.

Donald L. Trump, MD, a pioneer in vitamin D and prostate cancer research, has been named president and chief executive officer of Roswell Park Cancer Institute in Buffalo, NY. He succeeds David C. Hohn, MD, who stepped down to assume the roles of executive director of health policy and president emeritus.

The Roswell Park Cancer Institute board recruited Dr. Trump in 2002. Dr. Trump has served as the Institute’s senior vice president for clinical research and chair of the department of medicine before being named associate director in 2006.

David B. Samadi, MD, a leading urologic oncologist specializing in robotics and minimally invasive surgery for prostate cancer, has been named chief of the division of robotics and minimally invasive surgery in the department of urology at Mount Sinai Medical Center in New York.

Prior to joining Mount Sinai, Dr. Samadi served as director of robotic laparoscopic surgery in the department of urology at New York’s Columbia Presbyterian Hospital. Dr. Samadi has performed more than 800 robotic laparoscopic procedures, and frequently lectures and trains other urologists on the use of the da Vinci robotic surgical system.